Home » FDA Releases Slew of Warnings to Compounding Pharmacies
FDA Releases Slew of Warnings to Compounding Pharmacies
The FDA has stepped up its enforcement of compounding pharmacy quality violations that occurred before a new law took effect that boosted agency powers, a move that some industry players contend is unjust.
Drug GMP Report
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May